trametinib,pembrolizumab,dabrafenib
merck,novartis
[]
#neotrio study. another possibility in the neoadj. setting? braf/mek before pd-1 not better than pd-1 alone and triple combo tox still many open questions about the best neoadj strategy in #melsc what are your thoughts ? #asco22 
MedOnc ???? ???? #melanoma #Translationalresearch #mentoring
Chair @myESMO Young Oncologists Committee
ESMO Faculty Melanoma & Other Skin Cancers 
@CoE_iFIT